User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Journal article
    Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European intergroup trial
    de Witte, Theo Hagemeijer, Anne Suciu, Stefan Belhabri, Amin Delforge, Michel Kobbe, Guido Selleslag, Dominik Schouten, Harry C. Ferrant, Augustin[UCL] Biersack, Harald Amadori, Sergio Muus, Petra Jansen, Joop H. Hellström-Lindberg, Eva Kovacsovics, Tibor Wijermans, Pierre Ossenkoppele, Gert Gratwohl, Alois Marie, Jean-Pierre Willemze, Roel (2010) Haematologica : the hematology journal — Vol. 95, no. 10, p. 1754-1761 (2010)
    • Journal article
    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
    Ossenkoppele, Gert J Stussi, Georg Maertens, Johan van Montfort, Kees Biemond, Bart J Breems, Dimitri Ferrant, August[UCL] Graux, Carlos[UCL] de Greef, Georgine E Halkes, C J M Hoogendoorn, Mels Hollestein, Rene M Jongen-Lavrencic, Mojca Levin, Mark D van de Loosdrecht, Arjan A van Marwijk Kooij, Marinus van Norden, Yvette Pabst, Thomas Schouten, Harry C Vellenga, Edo Verhoef, Gregor E G de Weerdt, Okke Wijermans, Pierre Passweg, Jakob R Löwenberg, Bob (2012) Blood — Vol. 120, no. 24, p. 4706-4711 (2012)
    • Journal article
    High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
    Terwijn, Monique van Putten, Wim L J Kelder, Angèle van der Velden, Vincent H J Brooimans, Rik A Pabst, Thomas Maertens, Johan Boeckx, Nancy de Greef, Georgine E Valk, Peter J M Preijers, Frank W M B Huijgens, Peter C Dräger, Angelika M Schanz, Urs Jongen-Lavrecic, Mojca Biemond, Bart J Passweg, Jakob R van Gelder, Michel Wijermans, Pierre Graux, Carlos[UCL] Bargetzi, Mario Legdeur, Marie-Cecile Kuball, Jurgen de Weerdt, Okke Chalandon, Yves Hess, Urs Verdonck, Leo F Gratama, Jan W Oussoren, Yvonne J M Scholten, Willemijn J Slomp, Jennita Snel, Alexander N Vekemans, Marie-Christiane[UCL] Löwenberg, Bob Ossenkoppele, Gert J Schuurhuis, Gerrit J (2013) Journal of Clinical Oncology — Vol. 31, no. 31, p. 3889-3897 (2013)
    • Journal article
    Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
    Cornelissen, Jan J van Putten, Wim L J Verdonck, Leo F. Theobald, Matthias Jacky, Emanuel Daenen, Simon M G van Marwijk Kooy, Marinus Wijermans, Pierre Schouten, Harry Huijgens, Peter C van der Lelie, Hans Fey, Martin Ferrant, Augustin[UCL] Maertens, Johan Gratwohl, Alois Lowenberg, Bob (2007) Blood — Vol. 109, no. 9, p. 3658-66 (2007)
    • Journal article
    Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
    Heutte, Natacha Van Den Neste, Eric[UCL] Flechtner, Henning H Mounier, Nicolas Mellink, Wilhelmina Am Meerwaldt, Jacobus H Eghbali, Houchingue Van't Veer, Mars B Noordijk, Evert M Kluin-Nelemans, Johanna C Lampka, Elzbieta Thomas, José Lugtenburg, Pieternella J Viterbo, Luisa Carde, Patrice Hagenbeek, Anton van der Maazen, Richard Wm Smit, Wilma Gjm Brice, Pauline van Marwijk Kooy, Marinus Baars, Johanna W Poortmans, Philip Tirelli, Umberto Leeksma, Onno C Tomsic, Radka Feugier, Pierre Salles, Gilles Gabarre, Jean Kersten, Marie José Creemers, Geert-Jan M Gaillard, Isabelle Meijnders, Paul Tertian, Gérard Reman, Oumédaly Muller, Hein P Troncy, Jacques Blanc, Michel Schroyens, Wilfried Voogt, Paul J Wijermans, Pierre Rieux, Chantal Fermé, Christophe Henry-Amar, Michel (2009) The lancet oncology — Vol. 10, no. 12, p. 1160-70 (2009)
    • Journal article
    Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
    Giles, Francis Rizzieri, David Karp, Judith Vey, Norbert Ravandi, Farhad Faderl, Stefan Khan, Khuda Dad Verhoef, Gregor Wijermans, Pierre Advani, Anjali Roboz, Gail Kantarjian, Hagop Bilgrami, Syed Fazl Ali Ferrant, Augustin[UCL] Daenen, Simon M G J Karsten, Verena Cahill, Ann Albitar, Maher Mufti, Ghulam O'Brien, Susan (2007) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 25, no. 1, p. 25-31 (2007)